Terazosin Hydrochloride

규격

70024-40-7CAS 번호

[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochlorideIUPAC 명칭

C19H30ClN5O6화학식

459.9 g/mol분자량

Terazosin hydrochloride dihydrate; Urodie; Itrin; Hytracin; Abbott-45975; TEZRULY; Terazosin hcl 2h20; Terazosin (as hydrochloride); 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furoyl)piperazine monohydrochloride dihydrate; D32S14F082; NSC-759168; Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)-, monohydrochloride, dihydrate; CHEBI:9446; DTXCID5025493; Benph; RefChem:57179; 6,7-dimethoxy-2-(4-(tetrahydrofuran-2-ylcarbonyl)piperazin-1-yl)quinazolin-4-amine hydrochloride dihydrate; DTXSID7045493; Terazosin Hydrochloride; 70024-40-7; Heitrin; Magnurol; Terazosin HCl dihydrate; Hytrin; Flotrin; Hytrine; Dysalfa; Terazosin monohydrochloride dihydrate; Adecur; Deflox; Terazosin HCl hydrate; MFCD00941408; Terazosin (hydrochloride dihydrate); (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanone hydrochloride dihydrate; Terazosin hydrochloride hydrate; Vasocard; Vasomet; Zayasel; [4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(oxolan-2-yl)methanone;dihydrate;hydrochloride; Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](tetrahydro-2-furanyl)-, hydrochloride, hydrate (1:1:2); Hydracin; Isontyn; Sinalfa; Teralfa; Teraprost; Unoprost; Hitrin; Uroflo; Terazosin Abbot; Terazosin hydrochloride hydrate (JAN); TERAZOSIN HYDROCHLORIDE HYDRATE [JAN]; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonyl]piperazine hydrochloride; C19H30ClN5O6; UNII-D32S14F082; Hytrin BPH; [4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](tetrahydrofuran-2-yl)methanone Hydrochloride Dihydrate; METHANONE, (4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL)(TETRAHYDRO-2-FURANYL)-, HYDROCHLORIDE, HYDRATE (1:1:2); Hytrin (TN); Terazosin hydrochloride [USAN:USP:JAN]; Terazosin HCl (Hytrin); 70024-40-7 (HCl); 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-((tetrahydro-2-furanyl)carbonyl)piperazine HCl 2H2O; A-45975; SCHEMBL41544; Terazosin hydrochloride (USP); HY-B0371AR; orb1300542; orb3140158; CHEMBL3989562; SCHEMBL29361818; HY-B0371A; ABT-975; NZMOFYDMGFQZLS-UHFFFAOYSA-N; DTXSID801366621; GLXC-05614; HMS5080P21; MY-208; s2059; Terazosin hydrochloride dihydrate CRS; TERAZOSIN HYDROCHLORIDE [USAN]; AKOS015962345; AC-8239; CCG-269330; FT33939; KS-1119; NSC 759168; TERAZOSIN HYDROCHLORIDE [VANDF]; TERAZOSIN HYDROCHLORIDE [USP-RS]; TERAZOSIN HYDROCHLORIDE [WHO-DD]; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(tetrahydro-2-furanyl-)carbonyl)-piperazine hydrochloride dihydrate; BT164459; SY110999; Terazosin HCl dihydrate - Bio-X trade mark; SW196457-4; T6701; TERAZOSIN HYDROCHLORIDE [ORANGE BOOK]; TERAZOSIN HYDROCHLORIDE DIHYDRATE [MI]; C76229; D00610; Terazosin (hydrochloride dihydrate) (Standard); TERAZOSIN HYDROCHLORIDE [USP MONOGRAPH]; Terazosin monohydrochloride dihydrate [WHO-DD]; Q27108398; TERAZOSIN HYDROCHLORIDE DIHYDRATE [EP IMPURITY]; TERAZOSIN HYDROCHLORIDE DIHYDRATE [EP MONOGRAPH]; Terazosin hydrochloride, United States Pharmacopeia (USP) Reference Standard; Terazosin for system suitability, European Pharmacopoeia (EP) Reference Standard; Terazosin hydrochloride dihydrate, European Pharmacopoeia (EP) Reference Standard; Terazosin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material; (4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(tetrahydrofuran-2-yl)methanonehydrochloridedihydrate; [4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-tetrahydrofuran-2-yl-methanone;dihydrate;hydrochloride; 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine hydrochloride dihydrate; 1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate; Terazosina hidrocloruro dihidrato; Térazosine (chlorhydrate de) dihydraté동의어